Chishty Mansoor, Begley David J, Abbott N Joan, Reichel Andreas
Blood-Brain Barrier Research Group, Centre for Neuroscience Research, GKT School of Biomedical Sciences, King's College London, UK.
Neuroreport. 2003 May 23;14(7):1087-90. doi: 10.1097/01.wnr.0000072843.93264.ff.
Multiple nucleoside transport systems exist in the body yet the subtypes functional at the blood-brain barrier (BBB) have not been fully investigated. We have employed RBE4 immortalised rat brain endothelial cells to functionally identify the carrier subtypes involved in nucleoside transfer between blood and brain. Uptake in RBE4 cells was partially sodium dependent, indicating the presence of both equilibrative and concentrative systems. Uptake of adenosine via equilibrative transporters was sensitive to nitro-benzylmercaptopurine riboside, which showed biphasic inhibition. Uptake of [3H]-adenosine via concentrative transporters was studied using the subtype-specific inhibitors thymidine (cit), formycin-B (cif) and tubercidin (cib) and was significantly reduced by thymidine and formycin-B but not by tubercidin. This study suggests that nucleoside transport at the in situ BBB may be mediated by ei and es equilibrative transporters and by cit and cif concentrative transporters.
体内存在多种核苷转运系统,但在血脑屏障(BBB)发挥功能的亚型尚未得到充分研究。我们利用RBE4永生化大鼠脑内皮细胞,从功能上鉴定参与血液与脑之间核苷转运的载体亚型。RBE4细胞的摄取部分依赖于钠,这表明存在平衡型和浓缩型系统。通过平衡型转运体摄取腺苷对硝基苄基巯基嘌呤核糖苷敏感,表现出双相抑制作用。使用亚型特异性抑制剂胸苷(cit)、间型霉素-B(cif)和杀结核菌素(cib)研究了通过浓缩型转运体摄取[3H]-腺苷的情况,结果表明胸苷和间型霉素-B可显著降低摄取量,而杀结核菌素则无此作用。本研究表明,原位血脑屏障处的核苷转运可能由ei和es平衡型转运体以及cit和cif浓缩型转运体介导。